Core Viewpoint - Zhejiang Qianjiang Biochemical Co., Ltd. reported a decrease in total assets and operating income for the first half of 2025, while experiencing an increase in total profit and net profit attributable to shareholders [1][2]. Financial Performance - Total assets at the end of the reporting period were approximately 7.02 billion RMB, a decrease of 7.08% compared to the previous year [1]. - Operating income for the period was approximately 779.54 million RMB, down 9.64% from 862.66 million RMB in the same period last year [1]. - Total profit increased by 45.64%, reaching approximately 128.77 million RMB compared to 88.41 million RMB in the previous year [1]. - Net profit attributable to shareholders was approximately 56.74 million RMB, a decrease of 29.39% from 80.35 million RMB in the previous year [1]. Shareholder Information - The total number of shareholders as of the reporting period was 30,138 [2]. - The largest shareholder, Haining Water Investment Group Co., Ltd., holds a significant stake, while other notable shareholders include Yunnan Water Investment Co., Ltd. and Haining Asset Management Co., Ltd. [2].

Group 1 - The board of directors of Zhejiang Qianjiang Biochemical Co., Ltd. held its 13th meeting of the 10th session on August 26, 2025, with no absences or dissenting votes reported [1][2] - The board approved the 2025 semi-annual report and its summary, with a unanimous vote of 9 in favor and no opposition or abstentions [1][2] Group 2 - The board also approved a proposal to absorb and merge its wholly-owned subsidiary, Haining Jiahui Property Management Co., Ltd., to enhance operational efficiency and reduce management costs [2] - The merger will not constitute a related party transaction or a major asset restructuring as defined by regulations, and does not require shareholder approval [2]

股票简称：钱江生化 证券代码：600796 编号：临 2025-038 浙江钱江生物化学股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ??监事是否未能出席（亲自出席或委托出席）本次监事会：无。 ??有监事是否对本次监事会某项议案投反对/弃权票：无。 ??本次监事会是否有某项议案未获通过：无。 报告期内，公司的财务核算体制健全，会计事项的处理、财务报表的编制及 公司执行的会计制度符合有关法律法规的要求。公司 2025 年半年度报告及其摘 要编制和审议程序符合法律、法规、公司章程和公司内部管理制度的各项规定； 各项规定，所包含的信息能从各个方面真实地反映出公司当期的经营管理和财务 状况等事项，财务报告中的数据真实。 在提出本意见前，监事会没有发现参与 2025 年半年度报告及其摘要编制和 审议的人员有违反保密规定的行为。 表决结果：3 票同意、0 票反对、0 票弃权。 本次会议表决由监事朱炳其先生和朱霞芳女士进行计票和监票。 特此公告。 浙江钱江生物化学股份有限公司监事会 报备文件 十届十三次 ...

Group 1 - The company reported a revenue of 779,536,580.02 yuan for the first half of 2025, representing a year-on-year decrease of 9.64% [1] - The net profit attributable to shareholders of the listed company was 107,120,040.88 yuan, showing a year-on-year increase of 30.24% [1]

（文章来源：证券日报） 证券日报网讯 8月26日晚间，钱江生化发布公告称，公司十届十三次监事会会议审议通过了《公司2025 年半年度报告及其摘要》。 ...

（文章来源：证券日报） 证券日报网讯 8月26日晚间，钱江生化发布公告称，公司十届十三次董事会会议审议通过了《公司2025 年半年度报告及其摘要》等。 ...

Group 1 - Sichuan Gold achieved a net profit of 209 million yuan in the first half of 2025, a year-on-year increase of 48.41% [1] - Hai Xin Co. reported a net profit of 108 million yuan, up 5.62% year-on-year, despite a revenue decline of 8.35% [1] - Shanhe Pharmaceutical Auxiliary's net profit decreased by 2.61% to 93.04 million yuan, with a revenue increase of 4.65% [2] Group 2 - Donghua Software's net profit fell by 15.78% to 244 million yuan, with a slight revenue decline of 1.76% [2] - Zhongyuan Haike reported a significant net profit drop of 91.21% to 9.83 million yuan, alongside a revenue decrease of 9.97% [3] - Xingxin New Materials experienced a net profit decline of 21.72% to 33.64 million yuan, with a minimal revenue growth of 0.02% [4] Group 3 - Longban Media's net profit increased by 13.28% to 120 million yuan, despite a revenue drop of 24.01% [6] - Guangge Technology reported a net loss of 31.38 million yuan, worsening from a loss of 20.17 million yuan in the previous year, with a revenue increase of 71.44% [7] - Ge Ke Wei's net profit decreased by 61.59% to 29.76 million yuan, despite a revenue growth of 30.33% [8] Group 4 - Shaoyang Hydraulic's net profit fell by 31.68% to 7.11 million yuan, with a revenue decline of 12.84% [9] - Qianjiang Biochemical achieved a net profit of 107 million yuan, a year-on-year increase of 30.24%, despite a revenue decline of 9.64% [10] - Jianhui Information's net profit dropped by 82.99% to 502.52 million yuan, with a revenue increase of 9.03% [11] Group 5 - Nobon Co. reported a net profit of 65.33 million yuan, up 48.33% year-on-year, with a revenue increase of 33.35% [12] - Proya's net profit increased by 13.80% to 799 million yuan, with a revenue growth of 7.21% [13] - Huayuan Holdings reported a net loss of 22.48 million yuan, improving from a loss of 39.2 million yuan in the previous year, with a revenue decline of 94.74% [15] Group 6 - Chihong Zn & Ge's net profit increased by 3.27% to 932 million yuan, with a revenue growth of 7.67% [17] - Dae Oriental's net profit decreased by 45.33% to 59.04 million yuan, with a revenue decline of 5.20% [19] - Zhongnong Lihua's net profit fell by 10.06% to 142 million yuan, despite a revenue increase of 3.27% [20] Group 7 - Triangle Tire's net profit decreased by 35.31% to 396 million yuan, with a revenue decline of 4.50% [21] - Lianchuang Optoelectronics reported a net profit of 263 million yuan, up 15.18% year-on-year, with a revenue increase of 6.51% [22] - Taijing Technology's net profit fell by 61.59% to 22.04 million yuan, despite a revenue growth of 16.73% [23] Group 8 - Congsheng Co. announced plans to establish a wholly-owned subsidiary with an investment of 5 million yuan [24] - Yilian Network's net profit decreased by 8.84% to 1.24 billion yuan, with a slight revenue decline of 0.64% [25] - Weichuang Electric's net profit increased by 4.87% to 141 million yuan, with a revenue growth of 16.39% [26] Group 9 - Liuyuan Chemical reported a net loss of 149 million yuan, worsening from a profit of 29.37 million yuan in the previous year, with a revenue increase of 3.10% [28] - Luxshare Precision achieved a net profit of 6.644 billion yuan, a year-on-year increase of 23.13%, with a revenue growth of 20.18% [29] - Jiangfeng Electronics reported a net profit of 253 million yuan, up 56.79% year-on-year, with a revenue increase of 28.71% [30] Group 10 - Hongqiao Technology reported a net loss of 22.97 million yuan, worsening from a profit of 21.96 million yuan in the previous year, with a revenue decline of 11.76% [31] - Hong Sifang's net profit decreased by 47.10% to 43.97 million yuan, with a revenue decline of 8.18% [32] - Huaxia Happiness reported a net loss of 6.827 billion yuan, worsening from a loss of 4.849 billion yuan in the previous year, with a revenue decline of 50.90% [35] Group 11 - Watson Bio's net profit decreased by 74.69% to 43.16 million yuan, with a revenue decline of 19.47% [37] - Huayang Lianzhong's controlling shareholder plans to increase its stake by 1% to 2% [39] - Lanhua Ketech's net profit decreased by 89.58% to 57.48 million yuan, with a revenue decline of 26.05% [41] Group 12 - Aike Optoelectronics reported a net profit increase of 127.40% to 36.04 million yuan, with a revenue growth of 64.39% [43] - Guojia Automobile's net profit decreased by 14.32% to 21.3 million yuan, with a revenue decline of 11.64% [44] - Yingjia Gongjiu's net profit decreased by 18.19% to 1.13 billion yuan, with a revenue decline of 16.89% [46] Group 13 - China Shipbuilding Technology reported a net loss of 574 million yuan, worsening from a loss of 81.71 million yuan in the previous year, with a revenue increase of 30.79% [48] - Dayang Electric's net profit increased by 34.41% to 602 million yuan, with a revenue growth of 7.66% [49] - Shoukai Co. reported a net loss of 1.839 billion yuan, improving from a loss of 1.948 billion yuan in the previous year, with a revenue increase of 105.19% [51]

Group 1 - The core point of the article is that Qianjiang Biochemical (SH 600796) announced its board meeting to review the 2025 semi-annual report and its summary, indicating ongoing corporate governance and financial transparency [1] - For the year 2024, the revenue composition of Qianjiang Biochemical is as follows: wastewater treatment and recycling account for 28.2%, engineering installation and material sales for 22.76%, waste clearance and disposal for 18.53%, biological products for 14.5%, thermal power for 9.85%, and water treatment and supply for 5.43% [1] - As of the report, Qianjiang Biochemical has a market capitalization of 5.2 billion yuan [1] Group 2 - The article also highlights the booming pet industry, which is valued at 300 billion yuan, suggesting significant growth potential for companies in this sector [1] - The mention of a smart phone for pets indicates innovation and new product development within the pet industry, which may attract investment interest [1] - The overall positive sentiment in the pet industry is reflected in the rising stock prices of related listed companies [1]

证券代码：600796 证券简称：钱江生化 公告编号：2025-041 浙江钱江生物化学股份有限公司 关于为关联方提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 担 保 对 象 被担保人名称 海宁光耀热电有限公司 被担保人关联关系 □控股股东、实际控制人及其控制 的主体 ☑上市公司董事、监管、高级管理 人员及其控制或者任职的主体 □其他______________ 本次担保金额 1,964.285 万元 实际为其提供的担保余额 17,859.285 万元 是否在前期预计额度内 是 □否 □不适用：_________ 本次担保是否有反担保 是 ☑否 □不适用：_________ 累计担保情况 | 对外担保逾期的累计金额（万元） | 0.00 | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（万元） | 197,934.285 | | 对外担保总额占上市公司最近一 | 55.65 | | 期经审计净资产的比例（%） | | | | ☑对外担保总 ...

证券代码：600796 证券简称：钱江生化 公告编号：临 2025-040 本次投资者说明会以网络互动形式召开，公司将针对 2025 年半 年度的经营成果及财务指标的具体情况与投资者进行互动交流和沟 通，在信息披露允许的范围内就投资者普遍关注的问题进行回答。 浙江钱江生物化学股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 08 月 28 日 （星期四） 至 09 月 03 日 （星 期三）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目 或通过公司邮箱 qjbioch@600796.com 进行提问。公司将在说明会上 对投资者普遍关注的问题进行回答。 浙江钱江生物化学股份有限公司（以下简称"公司"）已于 2025 年 8 月 27 日发布公司 2025 年半年度报告，为便于广大投资者更全面 深入地了解公司 2025 年 ...